Form 4: Pratik Shah, Director and 10% Owner of ARS Pharmaceuticals, Reports Gift of Shares

Pratik Shah, a director and 10% owner of ARS Pharmaceuticals, reported a gift transaction involving common stock on June 7, 2024.

Summary

• On June 7, 2024, Pratik Shah, a director and 10% owner of ARS Pharmaceuticals, filed a Form 4.
• The filing reports a transaction where 1,332,950 shares of common stock were gifted from The Pratik Shah Living Trust to The Pratik Shah Trust.
• Following the transaction, Pratik Shah directly owns 0 shares and indirectly owns 4,824,554 shares through The Pratik Shah Living Trust and shares owned by spouse.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing reporting a gift of shares. It doesn't inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure of insider transactions, which are common and legally required for individuals holding significant positions in publicly traded companies. It provides transparency into the trading activities of company insiders.

Related Party Transactions

• The transaction involves a gift from The Pratik Shah Living Trust to The Pratik Shah Trust, where Mr. Shah's spouse is the sole beneficiary and Mr. Shah is the grantor.

Stakeholder Impact

• The transaction itself is unlikely to have a direct impact on stakeholders, as it is a transfer between trusts associated with a company insider.
• However, transparency in insider transactions is important for maintaining investor confidence.

Key Dates